Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion...
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics,...
It's a common thought that investing in biotech stocks is just too risky for the average investor - but that's not the case.
It's true...
Investing in biotech stocks is risky for those who haven't done enough research. But with just a couple of tips, investors can drastically...
